114 related articles for article (PubMed ID: 11922613)
61. Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats.
Liu H; Tang R; Pan WS; Zhang Y; Liu H
J Pharm Pharmacol; 2003 Nov; 55(11):1523-9. PubMed ID: 14713363
[TBL] [Abstract][Full Text] [Related]
62. Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models.
Berggren S; Hoogstraate J; Fagerholm U; Lennernäs H
Eur J Pharm Sci; 2004 Mar; 21(4):553-60. PubMed ID: 14998587
[TBL] [Abstract][Full Text] [Related]
63. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
Hiranuma T; Iwao K; Kitamura K; Matsumiya T; Oka T
J Pharmacol Exp Ther; 1997 May; 281(2):769-74. PubMed ID: 9152384
[TBL] [Abstract][Full Text] [Related]
64. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
Yamamoto A; Ukai H; Morishita M; Katsumi H
Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
[TBL] [Abstract][Full Text] [Related]
65. The in vitro intestinal absorption of enterostatin is limited by brush-border membrane peptidases.
Huneau JF; Erlanson-Albertsson C; Beauvallet C; Tomé D
Regul Pept; 1994 Dec; 54(2-3):495-503. PubMed ID: 7716282
[TBL] [Abstract][Full Text] [Related]
66. In vitro permeation of beta-lactam antibiotics across rat jejunum and its correlation with oral bioavailability in humans.
Saitoh H; Aungst BJ; Tohyama M; Hatakeyama Y; Ohwada K; Kobayashi M; Fujisaki H; Miyazaki K
Br J Clin Pharmacol; 2002 Oct; 54(4):445-8. PubMed ID: 12392595
[TBL] [Abstract][Full Text] [Related]
67. [Improvement of Intestinal and Transmucosal Absorption of Peptide and Protein Drugs].
Yamamoto A
Yakugaku Zasshi; 2024; 144(7):697-714. PubMed ID: 38945845
[TBL] [Abstract][Full Text] [Related]
68. [Improvement of transmucosal absorption of biologically active peptide drugs].
Yamamoto A
Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
[TBL] [Abstract][Full Text] [Related]
69. Enzymatic barriers to peptide and protein absorption.
Lee VH
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancement.
Sjöström M; Lindfors L; Ungell AL
Pharm Res; 1999 Jan; 16(1):74-9. PubMed ID: 9950282
[TBL] [Abstract][Full Text] [Related]
71. Targeting of peptide and protein drugs to specific sites in the oral route.
Bai JP; Chang LL; Guo JH
Crit Rev Ther Drug Carrier Syst; 1995; 12(4):339-71. PubMed ID: 9501967
[TBL] [Abstract][Full Text] [Related]
72. Intestinal absorption of stable heparinic acid complexes.
Koh TY; Bharucha KR
J Lab Clin Med; 1972 Jul; 80(1):47-55. PubMed ID: 5033896
[No Abstract] [Full Text] [Related]
73. Hexarelin--evaluation of factors influencing oral bioavailability and ways to improve absorption.
Westberg C; Benkestock K; Fatouros A; Svensson M; Sjöström B
J Pharm Pharmacol; 2001 Sep; 53(9):1257-64. PubMed ID: 11578108
[TBL] [Abstract][Full Text] [Related]
74. Development of new lipophilic derivatives of tetragastrin: physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats.
Tenma T; Yodoya E; Tashima S; Fujita T; Murakami M; Yamamoto A; Muranishi S
Pharm Res; 1993 Oct; 10(10):1488-92. PubMed ID: 8272412
[TBL] [Abstract][Full Text] [Related]
75. In vitro/in vivo models for peptide oral absorption: comparison of Caco-2 cell permeability with rat intestinal absorption of renin inhibitory peptides.
Conradi RA; Wilkinson KF; Rush BD; Hilgers AR; Ruwart MJ; Burton PS
Pharm Res; 1993 Dec; 10(12):1790-2. PubMed ID: 8302767
[No Abstract] [Full Text] [Related]
76. [Studies on intestinal absorption of proteolytic enzyme].
Yoshioka Y
Sapporo Igaku Zasshi; 1969; 36(1):41-52. PubMed ID: 5394087
[No Abstract] [Full Text] [Related]
77. Oral administration of peptides.
Saffran M
Endocrinol Exp; 1982 Nov; 16(3-4):327-33. PubMed ID: 6756894
[TBL] [Abstract][Full Text] [Related]
78. [The neuropeptide cholecystokinin and anxiety states].
Cohen H; Kaplan Z
Harefuah; 1996 May; 130(10):707-10. PubMed ID: 8794666
[No Abstract] [Full Text] [Related]
79. Routes of administration for bioactive drugs.
Reddy IK; Banga AK
J Pract Nurs; 1996 Sep; 46(3):43-8; quiz 49-50. PubMed ID: 8920485
[No Abstract] [Full Text] [Related]
80. [Effect of methanol, its metabolites and various stimulators and inhibitors of carbohydrate metabolism on isolated rabbit ileum].
Mazur M; Dzialek S; Lembke J; Cichowicz H
Agressologie; 1967; 8(6):551-7. PubMed ID: 5604567
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
